Publications by authors named "Maria C Mir"

Claim this Profile
T
The role of the human microbiome in prostate cancer: a systematic review from diagnosis to treatment.
Alfredo Distante, Davide Garino, Clara Cerrato, Javier Perez-Ardavin, Francisco Quereda Flores, Maria Carmen Mir

Prostate Cancer Prostatic Dis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating Tumor DNA in Muscle-invasive Bladder Cancer: Promise, Pitfalls, and Path Forward.
Clara Cerrato, Morgan Rouprêt, Maria Carmen Mir

Eur Urol Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiology of Renal Cancer: Incidence, Mortality, Survival, Genetic Predisposition, and Risk Factors.
Alessandro Larcher, Riccardo Campi, Axel Bex, Freddie Bray, Laura Bukavina, Maria Carmen Mir

Eur Urol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temporal trends and clinical determinants of urinary diversion after radical cystectomy.
Francesco Pellegrino, Mario de Angelis, Pietro Scilipoti, Mattia Longoni, José Daniel Subiela, Maria Carme Mir

BJU Int· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From vintage to vanguard: has chemoablation's prime time finally arrived in bladder cancer treatment?
Savio D Pandolfo, Maria Carmen Mir, Clara Cerrato, Pierluigi Russo, Celeste Manfredi

Minerva Urol Nephrol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world impact of cisplatin-based neoadjuvant chemotherapy on bladder cancer survival: a 20-year study.
Mario de Angelis, Francesco Pellegrino, Pietro Scilipoti, Mattia Longoni, Alfonso Santangelo, Maria Carme Mir

World J Urol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Re: Abdominal Noncontrast Computed Tomography Scanning to Screen for Kidney Cancer and Other Abdominal Pathology Within Community-based Computed Tomography Screening for Lung Cancer: Results of the Yorkshire Kidney Screening Trial.
Teele Kuusk, Maria Carmen Mir

Eur Urol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of Salvage Cystectomy After Prior Trimodality Therapy: A Multinational Match-paired Analysis.
Nikolaos Pyrgidis, Gerald Bastian Schulz, Pietro Scilipoti, Francesco Pellegrino, Jozefina Casuscelli, Maria Carmen Mir

Eur Urol Focus· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The potential benefits of concomitant statins treatment in patients with non-muscle-invasive bladder cancer.
Kang Liu, Rossella Nicoletti, Hongda Zhao, Xuan Chen, Peter Ka-Fung Chiu, Maria Carmen Mir

BJU Int· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Sex on the Oncological Outcomes in Response to Immunotherapy and Antibody-drug Conjugates in Patients with Urothelial and Kidney Cancer: A Systematic Review and a Network Meta-analysis.
Clara Cerrato, Fabio Crocerossa, Michele Marchioni, Gianluca Giannarini, Shilpa Gupta, Maria Carmen Mir

Eur Urol Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic role of histomorphological subtyping in nonmetastatic papillary renal cell carcinoma after curative surgery: is subtype really irrelevant? A propensity score matching analysis of a multi-institutional real life data.
Selcuk Erdem, Riccardo Bertolo, Riccardo Campi, Umberto Capitanio, Daniele Amparore, Maria Carme Mir

Urol Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does the Timing of Cytoreductive Nephrectomy Impact Outcomes? Analysis of REMARCC Registry Data for Patients Receiving Tyrosine Kinase Inhibitor Versus Immune Checkpoint Inhibitor Therapy.
Margaret F Meagher, Andrea Minervini, Maria C Mir, Clara Cerrato, Giacomo Rebez

Eur Urol Open Sci· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Significance of Grade Discrepancy Between Primary Tumor and Venous Thrombus in Nonmetastatic Clear-cell Renal Cell Carcinoma: Analysis of the REMEMBER Registry and Implications for Adjuvant Therapy.
Zhenjie Wu, Hui Chen, Qi Chen, Silun Ge, Nengwang Yu, Maria C Mir

Eur Urol Oncol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is solo indocyanine green-guided lymphadenectomy a feasible alternative to standard pelvic lymph node dissection?
Javier Perez-Ardavin, Maria Carmen Mir

BJU Int· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bladder cancer oligometastases - definition and treatment.
Laura S Mertens, Sarah P Psutka, Maria Carmen Mir

Nat Rev Urol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three-dimensional models-assisted minimally-invasive partial nephrectomy: looking forward to more evidence.
Riccardo Bertolo, Teele Kuusk, Maria C Mir,

Minerva Urol Nephrol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of smoking, hypertension and lifestyle factors on kidney cancer - perspectives for prevention and screening programmes.
Riccardo Campi, Giacomo Rebez, Tobias Klatte, Eduard Roussel, Idir Ouizad, Maria Carmen Mir

Nat Rev Urol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Re: Toni K. Choueiri, Thomas Powles, Laurence Albiges, et al. Cabozantinib plus Nivolumab and Ipilimumab in Renal-Cell Carcinoma. N Engl J Med 2023;388:1767-78.
Clara Cerrato, Benjamin Pradere, Maria Carmen Mir

Eur Urol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Robot-assisted Surgery in the Field of Urology: The Most Pioneering Approaches 2015-2023.
Antonio Franco, Francesco Ditonno, Celeste Manfredi, Andrew D Johnson, Avinash Mamgain, Maria Carmen Mir

Res Rep Urol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of cisplatin-based neoadjuvant chemotherapy on the renal function of patients undergoing radical cystectomy.
Matthew D Ho, Anna J Black, Homayoun Zargar, Adrian S Fairey, Laura S Mertens, Maria C Mir

Can Urol Assoc J· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer: Current Treatment Landscape and Novel Emerging Molecular Targets.
Francesco Claps, Nicola Pavan, Luca Ongaro, Domenico Tierno, Gabriele Grassi, Maria Carmen Mir

Int J Mol Sci· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma: a literature review.
Gabrielle Grob, Devin Rogers, Savio D Pandolfo, Srinivas Vourganti, Maurizio Buscarini, Maria C Mir

Transl Androl Urol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resection Techniques During Robotic Partial Nephrectomy: A Systematic Review.
Riccardo Bertolo, Alessio Pecoraro, Umberto Carbonara, Daniele Amparore, Pietro Diana, Maria Carmen Mir

Eur Urol Open Sci· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Utility of Inflammatory Serum Markers in the Assessment of Perioperative Morbidity after Radical Cystectomy for Bladder Cancer.
Francesco Claps, Giulio Rossin, Bas W G van Rhijn, Maria Carmen Mir, Laura S Mertens

Medicina (Kaunas)· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proposal for a Two-Tier Re-classification of Stage IV/M1 domain of Renal Cell Carcinoma into M1 ("Oligometastatic") and M2 ("Polymetastatic") subdomains: Analysis of the Registry for Metastatic Renal Cell Carcinoma (REMARCC).
Margaret F Meagher, Maria C Mir, Andrea Minervini, Maximilian Kriegmair, Matthias Heck, Mireia Musquera

Front Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis